These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36845105)

  • 1. The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56
    Ziegler AE; Fittje P; Müller LM; Ahrenstorf AE; Hagemann K; Hagen SH; Hess LU; Niehrs A; Poch T; Ravichandran G; Löbl SM; Padoan B; Brias S; Hennesen J; Richard M; Richert L; Peine S; Oldhafer KJ; Fischer L; Schramm C; Martrus G; Bunders MJ; Altfeld M; Lunemann S
    Front Immunol; 2023; 14():1117320. PubMed ID: 36845105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
    Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
    Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
    Maas RJ; Hoogstad-van Evert JS; Van der Meer JM; Mekers V; Rezaeifard S; Korman AJ; de Jonge PK; Cany J; Woestenenk R; Schaap NP; Massuger LF; Jansen JH; Hobo W; Dolstra H
    Oncoimmunology; 2020 Nov; 9(1):1843247. PubMed ID: 33224630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Characteristics of TIGIT-Expressing CD3
    Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
    Front Immunol; 2021; 12():602492. PubMed ID: 33717085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
    Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
    Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
    Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hobit expression by a subset of human liver-resident CD56
    Lunemann S; Martrus G; Goebels H; Kautz T; Langeneckert A; Salzberger W; Koch M; J Bunders M; Nashan B; van Gisbergen KPJM; Altfeld M
    Sci Rep; 2017 Jul; 7(1):6676. PubMed ID: 28751776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Transcription Factor Promyelocytic Leukemia Zinc Finger Protein Is Associated With Expression of Liver-Homing Receptors on Human Blood CD56
    Hess LU; Martrus G; Ziegler AE; Langeneckert AE; Salzberger W; Goebels H; Sagebiel AF; Hagen SH; Poch T; Ravichandran G; Koch M; Schramm C; Oldhafer KJ; Fischer L; Tiegs G; Richert L; Bunders MJ; Lunemann S; Altfeld M
    Hepatol Commun; 2020 Mar; 4(3):409-424. PubMed ID: 32140657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection.
    Zhang C; Wang H; Li J; Hou X; Li L; Wang W; Shi Y; Li D; Li L; Zhao Z; Li L; Aji T; Lin R; Shao Y; Vuitton DA; Tian Z; Sun H; Wen H
    Hepatology; 2021 Dec; 74(6):3376-3393. PubMed ID: 34192365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.
    Hudspeth K; Donadon M; Cimino M; Pontarini E; Tentorio P; Preti M; Hong M; Bertoletti A; Bicciato S; Invernizzi P; Lugli E; Torzilli G; Gershwin ME; Mavilio D
    J Autoimmun; 2016 Jan; 66():40-50. PubMed ID: 26330348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
    Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
    Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataloging circulating CD3
    Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bueno-Topete MR; Tellez-Bañuelos MC; Haramati J; Del Toro-Arreola S
    Immunol Lett; 2024 Oct; 269():106889. PubMed ID: 38945372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
    Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD56
    Chen T; Liu C; Li L; Liu H; Wang T; Shao Z; Fu R
    Int J Lab Hematol; 2019 Jun; 41(3):353-363. PubMed ID: 30779419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
    Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
    Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
    Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
    PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia.
    Yao D; Xu L; Liu L; Zeng X; Zhong J; Lai J; Zheng R; Jin Z; Chen S; Zha X; Huang X; Lu Y
    Biomed Res Int; 2020; 2020():9531549. PubMed ID: 33102599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint markers and anti-CD20-mediated NK cell activation.
    Wang Z; Weiner GJ
    J Leukoc Biol; 2021 Oct; 110(4):723-733. PubMed ID: 33615552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
    Vendrame E; Seiler C; Ranganath T; Zhao NQ; Vergara R; Alary M; Labbé AC; Guédou F; Poudrier J; Holmes S; Roger M; Blish CA
    AIDS; 2020 May; 34(6):801-813. PubMed ID: 32028328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.